The COVID‐19 Medicine Remdesivir Is Therapeutically Activated by Carboxylesterase‐1, and Excessive Hydrolysis Increases Cytotoxicity. Issue 9 (16th July 2021)

Record Type:: Journal Article
Title:: The COVID‐19 Medicine Remdesivir Is Therapeutically Activated by Carboxylesterase‐1, and Excessive Hydrolysis Increases Cytotoxicity. Issue 9 (16th July 2021)
Main Title:: The COVID‐19 Medicine Remdesivir Is Therapeutically Activated by Carboxylesterase‐1, and Excessive Hydrolysis Increases Cytotoxicity
Authors:: Shen, Yue
Eades, William
Yan, Bingfang
Abstract:
Is Part Of:: Hepatology communications. Volume 5:Issue 9(2021)
Journal:: Hepatology communications
Issue:: Volume 5:Issue 9(2021)
Issue Display:: Volume 5, Issue 9 (2021)
Year:: 2021
Volume:: 5
Issue:: 9
Issue Sort Value:: 2021-0005-0009-0000
Page Start:: 1622
Page End:: 1623
Publication Date:: 2021-07-16
Subjects:: Hepatology -- Periodicals
Liver -- Diseases -- Periodicals
Liver Diseases
Gastroenterology
Periodicals
Fulltext
Internet Resources
Periodicals
616.36
Journal URLs:: http://aasldpubs.onlinelibrary.wiley.com/hub/journal/10.1002/(ISSN)2471-254X/ ↗
http://onlinelibrary.wiley.com/ ↗
DOI:: 10.1002/hep4.1736 ↗
Languages:: English
ISSNs:: 2471-254X
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 26800.xml